In genetic polymorphisms analysis, the association between KRAS and VEGF 3’-UTR SNPs and CRC risk was further analyzed by tumor site, tumor size, differentiation degree, invasive depth and TNM staging. This evidence concerns the gene KRAS and neoplasm.